分子诊断市场按产品类型、应用、最终用户和地区划分

2025 年全球分子诊断市场规模预估为 183.6 亿美元，预计到 2032 年将达到 416.3 亿美元，2025 年至 2032 年的年复合成长率（CAGR）为 12.4%。

图。

分子诊断是一个正在发展的领域，它利用分子层面的生物标记（生物标记）分析来检测疾病、预测风险并确定新的治疗方案。分子诊断已成为现代医学的基本工具，帮助临床医生检测和监测疾病并指导治疗决策。透过 DNA序列测定和聚合酵素链锁反应(PCR) 等技术检测生物标记的能力彻底改变了医学检测并显着改善了患者的治疗效果。分子诊断技术的进步，加上基因定序成本的下降，正在推动其在各个应用领域的应用，包括传染病检查、肿瘤学和个人化医疗。持续的研究和发展有望进一步扩大分析能力，促进市场持续扩张。

市场动态

由于多种因素，全球分子诊断市场正在经历强劲成长。世界各地慢性病和感染疾病的增加推动了对先进诊断技术的需求。分子诊断测试可以比传统方法更早、更准确地发现疾病。个人化医疗和伴同性诊断的需求不断增长也是一个关键驱动因素，因为分子测试有助于确定对个别患者最有效的治疗方法。由于技术进步实现了更高通量筛检、自动化工作流程和分散测试环境，分子诊断能力正在不断扩大。然而，测试设备成本高和技术纯熟劳工的短缺阻碍了市场的成长。定序成本的持续降低和可携式、易于使用的仪器的开发为新的应用领域开闢了机会，特别是在分散的照护现场环境中。

研究的主要特点

本报告对全球分子诊断市场进行了详细分析，并以 2024 年为基准年，给出了预测期（2025-2032 年）的市场规模（十亿美元）和年复合成长率（CAGR%）。

它强调了各个领域的潜在商机并解释了该市场的有吸引力的投资提案矩阵。

它还提供了对市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景以及主要企业采用的竞争策略的重要见解。

它根据公司亮点、产品系列、关键亮点、财务表现和策略等参数，概述了全球分子诊断市场的主要企业。

本研究涉及的主要企业包括雅培实验室、碧迪公司、生物梅里埃公司、丹纳赫集团、Diasorin SPA、Hologic 公司、凯杰公司和罗氏诊断公司。

本报告的见解将使负责人和企业经营团队能够就未来产品发布、新兴趋势、市场扩张和行销策略做出明智的决策。

本研究报告针对该产业的各个相关人员，包括投资者、供应商、产品製造商、经销商、新进业者和财务分析师。

相关人员将透过全球分子诊断市场分析中使用的各种策略矩阵来做出决策。

目录

第一章 调查目的与前提条件

• 研究目标
• 先决条件
• 简称

第二章 市场展望

• 报告描述
  • 市场定义和范围
• 执行摘要

第三章市场动态、法规与趋势分析

• 市场动态
• 影响分析
• 监管情景
• 产品发布/核准
• PEST分析
• 波特分析
• 併购情景

4. 2025-2032 年全球分子诊断市场（按产品类型划分）（十亿美元）

• 介绍
• 试剂和套件
• 装置

5. 全球分子诊断市场，按应用划分，2025-2032 年（十亿美元）

• 介绍
• 肿瘤学
• 基因检测
• 微生物学
• 性行为感染传染病
• 血液检查
• 病毒学
• 组织学分型
• 产前检查
• 其他的

6. 2025-2032 年全球分子诊断市场（按最终用户划分）（十亿美元）

• 介绍
• 医院和诊断实验室
• 学术研究所
• 製药和生物技术公司
• 合约研究组织 (CRO)
• 照护现场环境

7. 2020 年至 2032 年全球分子诊断市场按地区分類的金额（十亿美元）

• 介绍
• 北美洲
• 美国
• 加拿大
• 拉丁美洲
• 巴西
• 阿根廷
• 墨西哥
• 其他拉丁美洲国家
• 欧洲
• 德国
• 英国
• 西班牙
• 法国
• 义大利
• 俄罗斯
• 其他欧洲国家
• 亚太地区
• 中国
• 印度
• 日本
• 澳洲
• 韩国
• 东南亚国协
• 其他亚太地区
• 中东
• 海湾合作委员会国家
• 以色列
• 其他中东地区
• 非洲
• 南非
• 北非
• 中部非洲

第八章 竞争格局

• Hoffmann-La Roche Ltd
• Illumina, Inc.
• Hologic, Inc.
• Agilent Technologies Inc.
• Qiagen NV
• Myriad Genetics
• Becton, Dickinson and Company
• Abbott Laboratories
• bioMerieux SA
• Bio-Rad Laboratories, Inc.
• Sysmex Corporation
• Danaher Corporation（Beckman Coulter Inc.）
• Thermo Fisher Scientific Inc.
• Siemens Healthineers AG
• Johnson & Johnson
• Alere Inc.
• Cepheid
• Gen-Probe Incorporated
• LabCorp（Monogram Biosciences）
• Novartis AG

第 9 章分析师建议

• 兴衰
• 一致的机会地图

第十章参考文献与调查方法

• 参考
• 调查方法
• 关于出版商

Global Molecular Diagnostics Market is estimated to be valued at USD 18.36 Bn in 2025 and is expected to reach USD 41.63 Bn by 2032, growing at a compound annual growth rate (CAGR) of 12.4% from 2025 to 2032.

Figure. Molecular Diagnostics Market Share (%), By Region 2025

Molecular diagnostics is an evolving field that involves the analysis of biological markers, or biomarkers, at the molecular level to test for diseases, predict risk or identify new therapeutic options. Molecular diagnostics has become a fundamental tool in modern healthcare, helping clinicians detect and monitor disease along with making treatment decisions. The ability to detect biomarkers through techniques such as DNA sequencing and polymerase chain reaction (PCR) has revolutionized medical testing and significantly improved patient outcomes. Advances in molecular diagnostic techniques coupled with the declining costs of genetic sequencing are helping drive widespread adoption across various applications areas such as infectious disease testing, oncology and personalized medicine. Continued research and development is further expanding analytical capabilities which is expected to contribute to the ongoing expansion of the market.

Market Dynamics:

The global molecular diagnostics market is witnessing strong growth driven by several factors. Rising prevalence of chronic and infectious diseases worldwide have increased the need for advanced diagnostic techniques. Molecular diagnostic tests offer earlier, more accurate detection of diseases compared to conventional methods. Growing demand for personalized medicine and companion diagnostics is another key driver as molecular tests help identify the most effective therapies for individual patients. Technological advancements enabling high-throughput screening, automated workflow processes and decentralized testing environments are expanding molecular diagnostic capabilities. However, high costs of instruments and lack of skilled labor restrain the market growth. Ongoing reductions in sequencing costs along with the development of portable, easy-to-use instruments opens opportunities in new applications areas, especially in decentralized, point-of-care settings.

Key Features of the Study:

This report provides in-depth analysis of the global molecular diagnostics market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global molecular diagnostics market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include Abbott Laboratories, Becton, Dickinson and Company, Biomerieux SA, Danaher Corporation, Diasorin SPA, Hologic Inc., QIAGEN N.V., Roche Diagnostics.

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

The global molecular diagnostics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global molecular diagnostics market.

Detailed Segmentation-

• By Product Type
  • Reagents & Kits
  • Instruments
• By Application
  • Oncology
  • Genetic Testing
  • Microbiology
  • STDs
  • Blood Screening
  • Virology
  • Tissue Typing
  • Prenatal Diagnosis
  • Others
• By End-user
  • Hospitals and Diagnostic Laboratories
  • Academic and Research Institutes
  • Pharmaceutical and Biotechnology Companies
  • Contract Research Organizations (CROs)
  • Point-of-Care Settings
• By Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa
• Key Players Insights
  • F. Hoffmann-La Roche Ltd
  • Illumina, Inc.
  • Hologic, Inc.
  • Agilent Technologies Inc.
  • Qiagen N.V.
  • Myriad Genetics
  • Becton, Dickinson and Company
  • Abbott Laboratories
  • bioMerieux SA
  • Bio-Rad Laboratories, Inc.
  • Sysmex Corporation
  • Danaher Corporation (Beckman Coulter Inc.)
  • Thermo Fisher Scientific Inc.
  • Siemens Healthineers AG
  • Johnson & Johnson
  • Alere Inc.
  • Cepheid
  • Gen-Probe Incorporated
  • LabCorp (Monogram Biosciences)
  • Novartis AG

Table of Contents

1. RESEARCH OBJECTIVES AND ASSUMPTIONS

• Research Objectives
• Assumptions
• Abbreviations

2. MARKET PURVIEW

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Global Molecular Diagnostics Market, By Product Type
  • Global Molecular Diagnostics Market, By Application
  • Global Molecular Diagnostics Market, By End-User
  • Global Molecular Diagnostics Market, By Region

3. MARKET DYNAMICS, REGULATIONS, AND TRENDS ANALYSIS

• Market Dynamics
• Impact Analysis
• Key Highlights
• Regulatory Scenario
• Product Launches/Approvals
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario

4. Global Molecular Diagnostics Market, By Product Type, 2025-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2020 - 2032
  • Segment Trends
• Reagents & Kits
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Instruments
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

5. Global Molecular Diagnostics Market, By Application, 2025-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2020 - 2032
  • Segment Trends
• Oncology
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Genetic Testing
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Microbiology
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• STDs
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Blood Screening
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Virology
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Tissue Typing
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Prenatal Diagnosis
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Molecular Diagnostics Market, By End-User, 2025-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2020 - 2032
  • Segment Trends
• Hospitals and Diagnostic Laboratories
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Academic and Research Institutes
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Pharmaceutical and Biotechnology Companies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Contract Research Organizations (CROs)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Point-of-Care Settings
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Molecular Diagnostics Market, By Region, 2020 - 2032, Value (USD Bn)

• Introduction
  • Market Share (%) Analysis, 2025,2028 & 2032, Value (USD Bn)
  • Market Y-o-Y Growth Analysis (%), 2020 - 2032, Value (USD Bn)
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, By Product Type , 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Application , 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End-User , 2020 - 2032, Value (USD Bn)
• U.S.
• Canada
• Latin America
  • Introduction
  • Market Size and Forecast, By Product Type , 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Application , 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End-User , 2020 - 2032, Value (USD Bn)
• Brazil
• Argentina
• Mexico
• Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, By Product Type , 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Application , 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End-User , 2020 - 2032, Value (USD Bn)
• Germany
• U.K.
• Spain
• France
• Italy
• Russia
• Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, By Product Type , 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Application , 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End-User , 2020 - 2032, Value (USD Bn)
• China
• India
• Japan
• Australia
• South Korea
• ASEAN
• Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, By Product Type , 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Application , 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End-User , 2020 - 2032, Value (USD Bn)
• GCC Countries
• Israel
• Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, By Product Type , 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Application , 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End-User , 2020 - 2032, Value (USD Bn)
• South Africa
• North Africa
• Central Africa

8. COMPETITIVE LANDSCAPE

• Hoffmann-La Roche Ltd
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Illumina, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Hologic, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Agilent Technologies Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Qiagen N.V.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Myriad Genetics
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Becton, Dickinson and Company
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Abbott Laboratories
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• bioMerieux SA
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Bio-Rad Laboratories, Inc.
• Sysmex Corporation
• Danaher Corporation (Beckman Coulter Inc.)
• Thermo Fisher Scientific Inc.
• Siemens Healthineers AG
• Johnson & Johnson
• Alere Inc.
• Cepheid
• Gen-Probe Incorporated
• LabCorp (Monogram Biosciences)
• Novartis AG

9. Analyst Recommendations

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

10. References and Research Methodology

• References
• Research Methodology
• About us